Dermatology
News from the FDA/CDC
FDA: Safety signal emerged with higher dose of tofacitinib in RA study
The FDA is working with Pfizer to better understand how the signal affects patients and how the drug should be used, the agency said in a...
News
FDA: More safety data needed for 12 sunscreen active ingredients
Only two – titanium dioxide and zinc oxide – are generally recognized as safe and effective and not misbranded, officials said.
News
AAD, NPF release two joint guidelines on treatment, management of psoriasis
The next guidelines will address phototherapy, topical therapy, nonbiologic systemic medications, and treatment of pediatric patients.
News
Trametinib effectively treats case of giant congenital melanocytic nevus
Intractable pain and pruritus resolved completely, which contributed to dramatic improvements in quality of life.
Video
Onychomycosis that fails terbinafine probably isn’t T. rubrum
WAIKOLOA, HAWAII – T. rubrum remains the most common cause of toenail fungus in the United States, but...
Conference Coverage
Tropical travelers’ top dermatologic infestations
WAIKOLOA, HAWAII – Leading the list: leishmaniasis, tungiasis, myiasis, and cutaneous larva migrans.
Video
How to surf the rosacea treatment algorithm
WAIKOLOA, HAWAII – Papules and pustules should be treated with an anti-inflammatory drug.
Video
Don’t fear spironolactone, isotretinoin, OCs for acne
WAIKOLOA, HAWAII – Old concerns regarding these treatment options are falling by the wayside.
Conference Coverage
When to suspect a severe skin reaction to an AED
NEW ORLEANS – Although most eruptions are benign, certain symptoms raise concerns about rare and potentially fatal antiepileptic drug reactions....